Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Te Mate Pūkahukahu Lymphoblastic Koretake (B-ALL)-03

Tūroro:Mr. Sun

Ira tangataTāne

Tau39 tau te pakeke

Iwi: Hainamana

TātaritangaTe Mate Pūkahukahu Lymphoblastic Koretake (B-ALL)

    Ngā Āhuatanga o te Pūkoro:

    - I kitea he mate toto toto pūkahukahu pūtau-B i te mutunga o Mei 2020.

    - Te whakamātautau toto: WBC 5.14x10^9/L, HGB 101.60g/L, PLT 6x10^9/L.

    - Te āhua o te hinu wheua: He iti te pūtau me te 67% o ngā pūtau toto taketake.

    - Te tātaritanga rere o te pūtau: 82.28% o ngā pūtau e whakaatu ana i te CD38, HLA-DR, CD19, CD10, CD105, TDT, CD22, cCD79a, e whakaatu ana i te CD9 i te taha, e whakaatu ngoikore ana i te CD13.

    - Kāore i kitea he ira whakakotahi e pā ana ki te PH, he pai te WT1 57.3%; kāore i kitea he ira whakakotahi e pā ana ki te ALL.

    - IKA: He pai te whakarerekētanga TP53.

    - Ngā ira-ira: 63-58, XXY, +Y, +1, +del(1)(q41q42), -2, -3, +6, -7, +8, -9, +10, -12, -13, +14, +15, -17, +18, -20, +22(cp16)/46, XY[4].

    - I whiwhi i te maimoatanga VCDLP mō ngā akoranga e rua, kāore he murunga.

    - Te rongoā CAM-VL (CTX 2gx2, Arac 200mgx6, 6-MP 100mgx14, VDS 4mgx2, L-ASP 10,000 IUx7) i te 22 o Hūrae, 2020, kāore anō kia murua.

    - Te whakamātautau rere o te hinu wheua i te 25 o Hepetema, 2020: 7.35% o ngā pūtau e whakaatu ana i te CD81, CD19, CD10, CD38, CD33, me te CD20, CD45 e whakaatu ngoikore ana.

    - Tātaritanga ira whakarerekētanga o te pukupuku toto: ira whakarerekētanga TP53.

    - Ngā ira-ira: 46, XY[20].

    - I tīmata te rongoā CD19-CART.

    - Te rongoā FC (REWHA 62.7mg x 4 rā, CTX 1045mg x 2 rā) rongoā chemotherapy.

    - 1 o Oketopa, 2020: Te werohanga pūtau CD19-CART aunoa i te 4.7x10^7/kg.

    - CRS taumata 2 me te paitini roro taumata 1, i pai ake i muri i te maimoatanga tautoko.

    - 29 Oketopa 2020: Kua tino marino te āhua o te hinu wheua, kāore he pūtau kino taketake i runga i te ine ira.

    - 31 Hakihea 2020: Maremare maroke, whakapairuaki, ruaki, ngoikore whānui.

    - Te whakamātautau toto: WBC 15.53x10^9/L, HGB 134g/L, PLT 71x10^9/L.

    - Ko te mimiti o te hinu wheua e tohu ana i te hokinga mai o te mate.

    - 2 o Hānuere, 2021: I whakaurua ki tō mātou hōhipera.

    - Te whakamātautau toto: WBC 20.87x10^9/L, HGB 118.30g/L, PLT 58.60x10^9/L.

    - Creatinine 134umol/L, toto toto tiketike wāhanga 3, hītori hauora o 4 tau.

    - Te whakarōpūtanga toto ā-taha: 62% ngā pūtau taketake.

    - Te Tātaritanga Ārai Mate: 28.48% o ngā pūtau (ngā pūtau whai pūtake) e whakaatu ana i te CD10, CD38dim, HLA-DR, CD20dim, CD24, CD81, cCD79a, CD22, CD268dim, CD58, e whakaatu ana i te CD123, TDT, kāore e whakaatu i te CD34, CD19, MPO, CD117, CD13, CD33, CD11b, clgM, CD79b, CD7, cCD3, kappa, lambda, e tohu ana i ngā pūtau toto kino taketake B.

    - Tātaritanga ira whakarerekētanga toto: he pai te ira whakarerekētanga TP53 R196P.


    Te maimoatanga:

    - I whiwhi i te rongoā VLP chemotherapy, me te rongoā mō te toto toto tiketike, te whakaiti i te creatinine, me te whakapūmau i te waikawa.

    - Hanuere 19: I whakaatuhia e te mahinga toto he WBC 1.77x10^9/L, HGB 71g/L, PLT 29.8x10^9/L.

    - Whakarōpūtanga toto ā-taha: Kāore he lymphocytes taketake.

    - Te āhua o te hinu wheua: Te nui o ngā pūtau (tohu V), ngā wāhi matua o te tohu IV, me te 42% o ngā pūtau toto taketake.

    - Ine rere o te pūtau: 13.91% o ngā pūtau e whakaatu ana i te CD10, cCD79a, CD38, CD81, CD22, kāore e whakaatu i te CD20, CD34, CD19, e tohu ana i ngā pūtau B taketake kino.

    - Te momo ira tangata:

    - 35,XY,-2,-3,-4,-5,-7,-9,-12,-13,-16,-17,-20[8]/35,XY,+X,-2,-3,-4,-5,-7,-9,-10,-12,-13,-16,-17,-20[1]/36,XY,tāpiri(1)(q42),-2,-3,-4,-7,-9,-12,-13,-16,-17,-20[1]/46,XY[20].

    - Hanuere 20: I kohia ngā pūtau lymphocyte mō te ahurea pūtau CD22-CART.

    - Hanuere 21: I mahia te pokanga o te lumbar, i tukuna te chemotherapy intrathecal hei ārai i te leukemia pūnaha io matua; kāore he āhuatanga rerekē i kitea i roto i te whakamātautau wai cerebrospinal.

    - 22 o Hānuere: I whiwhi i te rongoā Arac, 6MP, L-ASP chemotherapy, me te rongoā FC (Flu 50mg x 3, CTX 0.5gx 3).

    - 7 o Pēpuere (i mua i te werohanga): I whakaatuhia e te āhua o te hinu wheua he 93% o ngā pūtau toto taketake.

    - Te tātaritanga rere o te pūtau: 76.42% o ngā pūtau e whakaatu ana i te CD38, cCD79a, CD22, cbcl-2, CD123, CD10bri, CD24, CD81, kāore e whakaatu i te CD4, CD3, CD13+33, CD34, CD20, CD19, CD279 (PD1), CD274 (PDL1), he tohu tēnei mō ngā pūtau B taketake kino.

    - Kua pā mai te mate kiri me ngā kiko ngohengohe me te kirika; kua pai ake i muri i te rongoā paturopi.

    - 9 o Pēpuere: Te werohanga pūtau CD22-CART aunoa (5x10^5/kg).

    - Ngā pānga taha e pā ana ki te CAR-T: CRS taumata 1, kirika i te Rā 6 me te Tmax 40°C, pāmahana whakahaeretia i te Rā 10; kāore he paitini roro.

    - Maehe 11: I whakaatuhia e te aromatawai hinu wheua te murunga katoa o te āhua, kāore i whakaatuhia e te flow cytometry ngā pūtau kino taketake.

    11jbp

    whakaahuatanga2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write